Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
LAML | rs113010684 | chr13:114615754 | G/A | 4.7E-7 | 111 | 13.1 | 19.82 | 0.5 | KM Plot |
LAML | rs113129259 | chr19:33967636 | C/T | 2.15E-5 | 110 | 16.77 | 12.2 | 3 | KM Plot |
LAML | rs113145978 | chr7:1000578 | G/C | 3.08E-5 | 106 | 13.1 | 20.27 | 0 | KM Plot |
LAML | rs113297557 | chr13:21844412 | T/C | 1.06E-8 | 109 | 16.2 | 13.1 | 0 | KM Plot |
LAML | rs11334012 | chr11:93188856 | TA/T | 6.87E-5 | 108 | 6.13 | 12.17 | 16.3 | KM Plot |
LAML | rs11340609 | chr14:90765423 | CT/C | 5.64E-5 | 110 | 2.02 | 21.87 | 12.7 | KM Plot |
LAML | rs1134389 | chr19:12542772 | C/T | 1.87E-5 | 111 | 6.13 | 22.37 | 13.1 | KM Plot |
LAML | rs11348441 | chr11:34290340 | GA/G | 0.000145 | 111 | 14.18 | 15.77 | 0 | KM Plot |
LAML | rs113489856 | chr13:114617056 | C/T | 4.7E-7 | 111 | 13.1 | 19.82 | 0.5 | KM Plot |
LAML | rs113553167 | chr13:114953991 | G/A | 4.33E-6 | 107 | 13.15 | 17.2 | 0 | KM Plot |
LAML | rs113607209 | chr2:240547865 | G/A | 0.000174 | 106 | 13.2 | 33.47 | 0 | KM Plot |
LAML | rs11373933 | chr4:99037403 | C/CA | 0.000172 | 110 | 13.15 | 23.3 | 0 | KM Plot |
LAML | rs113847938 | chr13:114926352 | T/G | 3.67E-5 | 110 | 13.2 | 19.33 | 2.55 | KM Plot |
LAML | rs113848315 | chr19:33911608 | A/AAAAT | 3.87E-5 | 107 | 18.23 | 16.3 | 2.02 | KM Plot |
LAML | rs113926595 | chr1:95395616 | C/T | 9.48E-5 | 111 | 13.1 | 22.83 | 0 | KM Plot |